SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form 10-Q - Quarterly report [Sections 13 or 15(d)]:
SEC Accession No. 0000950170-23-060718
Filing Date
2023-11-08
Accepted
2023-11-08 09:07:14
Documents
52
Period of Report
2023-09-30

Document Format Files

Seq Description Document Type Size
1 10-Q coya-20230930.htm   iXBRL 10-Q 1613568
2 EX-31.1 coya-ex31_1.htm EX-31.1 24999
3 EX-31.2 coya-ex31_2.htm EX-31.2 24503
4 EX-32.1 coya-ex32_1.htm EX-32.1 18309
  Complete submission text file 0000950170-23-060718.txt   5795459

Data Files

Seq Description Document Type Size
5 XBRL TAXONOMY EXTENSION LABEL LINKBASE DOCUMENT coya-20230930_lab.xml EX-101.LAB 349623
6 XBRL TAXONOMY EXTENSION CALCULATION LINKBASE DOCUMENT coya-20230930_cal.xml EX-101.CAL 23218
7 XBRL TAXONOMY EXTENSION PRESENTATION LINKBASE DOCUMENT coya-20230930_pre.xml EX-101.PRE 267147
8 XBRL TAXONOMY EXTENSION SCHEMA DOCUMENT coya-20230930.xsd EX-101.SCH 38817
9 XBRL TAXONOMY EXTENSION DEFINITION LINKBASE DOCUMENT coya-20230930_def.xml EX-101.DEF 142231
46 EXTRACTED XBRL INSTANCE DOCUMENT coya-20230930_htm.xml XML 900713
Mailing Address 12645 MEMORIAL DR., SUITE F1 #305 HOUSTON TX 77024
Business Address 12645 MEMORIAL DR., SUITE F1 #305 HOUSTON TX 77024 650.739.3939
Coya Therapeutics, Inc. (Filer) CIK: 0001835022 (see all company filings)

IRS No.: 000000000 | State of Incorp.: DE | Fiscal Year End: 1231
Type: 10-Q | Act: 34 | File No.: 001-41583 | Film No.: 231386253
SIC: 2834 Pharmaceutical Preparations